Skip to content

Nevisense

Nevisense Base Unit 4B Screen new software 2025 with curve EU LOWRES croped

Discover the power of advanced skin diagnostics
Nevisense is SciBase’s unique technology for advanced skin diagnostics and research. Combining EIS with AI-powered analysis, Nevisense enables clinicians and researchers to uncover information hidden below the surface of the skin.

Utilizing EIS and AI

Nevisense uses Electrical Impedance Spectroscopy (EIS) to measure the skin’s bioelectrical signature across multiple frequencies and depths. This non-invasive technology generates detailed data reflecting tissue structure and cellular organization—delivering objective insights that support early detection, accurate assessment, disease monitoring and greater diagnostic confidence.
ChatGPT Image 15 sep. 2026 11_18_32 (3)

Measure

Nevisense applies small, imperceptible signals through the electrode at multiple frequencies and depths. The skin’s response reflects properties related to cellular structure, composition, and orientation. Nevisense collects approximately
700 data points.

ChatGPT Image 15 sep. 2026 11_18_32 (2)

Analyze

Application-specific algorithms transform the collected data into clear, quantitative information for clinical or research use.

Rooted in research from Karolinska Institutet of Sweden
The technology behind Nevisense originated from more than 20 years of research at Karolinska Institutet in Stockholm. It has since been developed into a clinically validated platform for skin cancer detection and skin-barrier assessment.
Scibase_utan_fonster_mobile

 

Applications: From cancer detection to skin barrier research

CE-marked and FDA-approved for melanoma detection, and CE-marked for keratinocyte cancers such as BCC and SCC.
Beyond cancer, it is increasingly used in dermatological research and product development.
Clinical Applications:
  • Melanoma detection: High-sensitivity tool to support melanoma management (Ref. 1)

Research Applications:

  • Skin Barrier Assessment: Valuable for atopic dermatitis, eczema, and other skin conditions.
  • Cosmetic testing: Quantifies effects of skincare products on the skin barrier.
IMG_0805

MELANOMA DETECTION

Our unique technology supporting clinicians in melanoma management.

See clinical applications
254A9875-1-1

SKIN BARRIER
ASSESSMENT

Nevisense supports researchers and product developers worldwide.

Learn about research use

Built for clinical- and research workflows

Nevisense is designed for everyday use. The measurement process is non-invasive, patient-friendly, and helps guide real-time decisions. In research, you can export data for deeper analysis, documentation, or longitudinal tracking. With a compact, portable device and an easy-to-use interface, Nevisense integrates smoothly into clinical practice and research environments alike.

Examin_Back_Nevisense-1-1
IMG_1707

Scientifically validated, globally trusted

Nevisense is backed by over three decades of research and extensive scientific publications. With 500,000 evaluations worldwide and more than 500 clinics using Nevisense for skin cancer detection, it is a trusted tool for dermatologists, academic researchers and life science companies.

Clinical trials have shown that Nevisense improves diagnostic performance when used alongside traditional examination methods, supporting better outcomes for patients and clinicians.

Get in touch with us

Book a personalized demonstration to learn how Nevisense can complement your current diagnostic process and provide objective support for clinical decision-making.
References:
1. Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multi-center, prospective and blinded clinical trial on efficacy and safety, Malvehy et al BJD, 2014 DOI: 10.1111/bjd.13121.